Schedule and dosage modification of a cyclophosphamide, hexamethylmelamine, doxorubicin, cisplatin combination chemotherapy regimen for refractory ovarian cancer
- 1 September 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (9) , 1273-1279
- https://doi.org/10.1016/0277-5379(89)90073-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Advanced Ovarian Cancer: Long-Term Results of Treatment with Intensive Cisplatin-Based Chemotherapy of Brief DurationAnnals of Internal Medicine, 1988
- Advanced ovarian cancer: Three-year results of a 6–8 month, 2-drug cisplatin-containing regimenEuropean Journal of Cancer and Clinical Oncology, 1987
- PROGNOSTIC FACTORS - CISPLATIN REGIMENS FOR PATIENTS WITH OVARIAN-CANCER AFTER FAILURE OF CHEMOTHERAPY1987
- Circadian Timing of Cancer ChemotherapyScience, 1985
- High-Dose Cisplatin in Hypertonic SalineAnnals of Internal Medicine, 1984
- High-dose platinum for the treatment of refractory ovarian cancerGynecologic Oncology, 1981